The group’s research contributes to advancing scientific excellence in understanding the effects of emerging contaminants on human health, with a particular focus on microplastics and nanoplastics. The knowledge generated has scientific, regulatory, clinical, industrial, and societal impacts.
Scientific impact
- Development of innovative New Approach Methodologies (NAMs) for risk assessment.
- Identification of molecular mechanisms involved in the toxicity and carcinogenicity of emerging contaminants.
- Identification of exposure and effect biomarkers for human health monitoring.
Public health and clinical impact
- Identification of vulnerable populations and high-risk groups.
- Enhancement of human biomonitoring strategies.
- Generation of scientific evidence to support the early prevention of diseases associated with environmental exposures.
Regulatory and public policy impact
- Provision of scientific support to national and international regulatory bodies.
- Contribution to the development of evidence-based risk assessment strategies grounded in mechanistic data.
- Participation in standardisation initiatives, harmonisation of methodologies, and development of Adverse Outcome Pathways (AOPs).
Industrial Impact and Innovation
- Promotion of the development of safer and more sustainable materials.
- Implementation of Safe and Sustainable by Design (SSbD) principles.
- Transfer of knowledge to industry and companies involved in the circular economy.
Social impact
- Public awareness of the risks associated with emerging contaminants.
- Promotion of preventive behaviours based on scientific evidence.
- Active societal participation in the co-creation of solutions to protect human health and the environment.